Entity
  • Prokarium

    Created in 2012
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    310 3,601
  • Activities

  • Technologies

  • Entity types

  • Location

    2 Royal College St, London NW1 0PB, UK

    London

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 22

  • Engaged corporates

    5
    0 2
  • Added in Motherbase

    3 years, 5 months ago
Description
  • Value proposition

    LIVING CURES

    Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects.

    Biotechnology, Vaccines, Oral delivery, Immunology, Synthetic Biology, Oncology, Microbial Immunotherapy, and Immunotherapy

Corporate interactions BETA
Corporate TypeTweets Articles
OECD - OCDE
OECD - OCDE
International development, International Affairs
OECD - OCDE
International development, International Affairs
Other

28 Apr 2024


UK Research and Innovation
UK Research and Innovation
Public business cluster, Government Administration
UK Research and Innovation
Public business cluster, Government Administration
Other

19 Mar 2024


McKinsey & Company
McKinsey & Company
Consulting, Business Consulting and Services
McKinsey & Company
Consulting, Business Consulting and Services
Other

2 Oct 2023


Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research
Other

2 Oct 2023


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

2 Oct 2023


Similar entities
Loading...
Loading...
Social network dynamics